We are excited to welcome KromaTiD as the newest PTRME ecosystem member! KromaTiD is a company specializing in genomic integrity analysis. It provides advanced tools and services for research and commercialization teams working with regenerative medicine technologies.
KromaTiD’s KROMASURE™ platform offers biomarker identification and genome analysis to accelerate the development of life-changing technologies through precise genomic analysis. Its proprietary technology, directional
Genomic Hybridization (dGH™), allows the direct observation of both intended and unintended genome modifications—an invaluable tool for advancing cell and gene technology translation and commercialization.
We’re thrilled to have KromaTiD join our ecosystem and look forward to the impact of its innovative technology. Learn more about KromaTiD.
To learn how you can become a partner of the PTRME, visit our Join Our Ecosystem page.